Tiffany D.
- Country
- France
- Department
- Oncology
Research Overview
- Evaluation of Temozolomide Monotherapy in Adult Patients with Non-Enhancing Diffuse Brainstem Gliomas Exhibiting Infiltrative Progression
- Evaluation of Darolutamide Combined with Stereotactic Body Radiation Therapy in Castration-Resistant Prostate Cancer with Oligometastases Detected by Functional Imaging
- Efficacy Comparison of Nivolumab-Ipilimumab Versus Immune Checkpoint Inhibitor-VEGFR TKI Combinations in Untreated Metastatic Renal Cell Carcinoma
Data & Insights
Has run more than one trial at 59 of 215 partner sites.
Specializations
Urological Oncology
Specializes in advanced treatment approaches for metastatic renal cell carcinoma and urothelial cancer, with particular focus on immune checkpoint inhibitor combinations and targeted therapies.
- Immunotherapy optimization in mRCC
- VEGFR-TKI combination strategies
- Advanced bladder cancer management
Investigates treatment pauses and continuation strategies in specific patient populations.
Genitourinary Oncology
Focuses on innovative treatments for castration-resistant prostate cancer and germ cell tumors, incorporating advanced imaging and targeted therapeutic approaches.
- Oligometastatic prostate cancer treatment
- Radiation therapy optimization
- Thromboprophylaxis in germ cell tumors
Explores combination therapies involving radiation and novel therapeutic agents.
Rare Tumors
Dedicated to advancing treatment options for uterine leiomyosarcoma and brainstem gliomas, with emphasis on post-operative care and chemotherapy strategies.
- Adjuvant therapy in sarcomas
- Neuro-oncology treatments
- Biomarker-guided therapy
Evaluates novel therapeutic approaches for rare and challenging malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.